Beta-actin, a critical player in cellular functions ranging from cell motility and the maintenance of cell shape to transcription regulation, was evaluated in the erythrocyte membranes from patients with typical Rett syndrome (RTT) and methyl CpG binding protein 2 (MECP2) gene mutations. RTT, affecting almost exclusively females with an average frequency of 1:10,000 female live births, is considered the second commonest cause of severe cognitive impairment in the female gender. Evaluation of beta-actin was carried out in a comparative cohort study on red blood cells (RBCs), drawn from healthy control subjects and RTT patients using mass spectrometry-based quantitative analysis. We observed a decreased expression of the beta-actin isoforms (relative fold changes for spots 1, 2 and 3: ？1.82±0.15, ？2.15±0.06, and ？2.59±0.48, respectively) in pathological RBCs. The results were validated by western blotting and immunofluorescence microscopy. In addition, beta-actin from RTT patients also showed a dramatic increase in oxidative posttranslational modifications (PTMs) as the result of its binding with the lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE). Our findings demonstrate, for the first time, a beta-actin down-regulation and oxidative PTMs for RBCs of RTT patients, thus indicating an altered cytoskeletal organization.
References
[1]
Dominguez R, Holmes KC (2011) Actin structure and function. Annu Rev Biophys 40: 169–86. doi: 10.1146/annurev-biophys-042910-155359
[2]
Herman IM (1993) Actin isoforms. Curr Opin Cell Biol 5: 48–55. doi: 10.1016/s0955-0674(05)80007-9
[3]
Kaufmann WE, Moser HW (2000) Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 10: 981–91. doi: 10.1093/cercor/10.10.981
[4]
Kunze D, Rüstow B (1993) Pathobiochemical aspects of cytoskeleton components. Eur J Clin Chem Clin Biochem 31: 477–89. doi: 10.1515/cclm.1993.31.8.477
[5]
Kaufmann WE, MacDonald SM, Altamura CR (2000) Dendritic cytoskeletal protein expression in mental retardation: an immunohistochemical study of the neocortex in Rett Syndrome. Cereb Cortex 10: 992–1004. doi: 10.1093/cercor/10.10.992
[6]
Amir RE, Van den Veyver IB, Wan Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–8. doi: 10.1038/13810
[7]
Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, et al. (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68: 944–50. doi: 10.1002/ana.22124
[8]
Bienvenu T, Chelly J (2006) Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet 7: 415–26. doi: 10.1038/nrg1878
[9]
Armstrong D, Dunn JK, Antalffy B, Trivedi R (1995) Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 54: 195–201. doi: 10.1097/00005072-199503000-00006
[10]
Kishi N, Macklis JD (2010) MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Exp Neurol 222: 51–8. doi: 10.1016/j.expneurol.2009.12.007
[11]
Fukuda T, Itoh M, Ichikawa T, Washiyama K, Goto Y (2005) Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 64: 537–44.
[12]
Belichenko PV, Wright EE, Belichenko NP, Masliah E, Li HH, et al. (2009) Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol 514: 240–58. doi: 10.1002/cne.22009
[13]
Belichenko NP, Belichenko PV, Mobley WC (2009) Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol Dis 34: 71–7. doi: 10.1016/j.nbd.2008.12.016
[14]
Smrt RD, Eaves-Egenes J, Barkho BZ, Santistevan NJ, Zhao C (2007) Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis 27: 77–89. doi: 10.1016/j.nbd.2007.04.005
[15]
Abuhatzira L, Shemer R, Razin A (2009) MeCP2 involvement in the regulation of neuronal alpha-tubulin production. Hum Mol Genet 18: 1415–23. doi: 10.1093/hmg/ddp048
[16]
Delépine C, Nectoux J, Bahi-Buisson N, Chelly J, Bienvenu T (2013) MeCP2 deficiency is associated with impaired microtubule stability. FEBS Lett 587: 245–53. doi: 10.1016/j.febslet.2012.11.033
[17]
Ciccoli L, De Felice C, Paccagnini E, Leoncini S, et al. (2012) Morphological changes and oxidative damage in Rett Syndrome erythrocytes. Biochim Biophys Acta 1820: 511–20. doi: 10.1016/j.bbagen.2011.12.002
[18]
Neul JL, Kaufmann WE, Glaze DG (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68: 944–50. doi: 10.1002/ana.22124
[19]
Dodge TG, Mitchell RG, Hanahan DJ (1963) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100: 119–30. doi: 10.1016/0003-9861(63)90042-0
[20]
Laemmli OK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–85. doi: 10.1038/227680a0
[21]
Go？rg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21: 1037–53. doi: 10.1002/(sici)1522-2683(20000401)21:6<1037::aid-elps1037>3.3.co;2-m
[22]
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–54. doi: 10.1006/abio.1976.9999
[23]
Hellman U, Wernstedt C, Gó？ez J, Heldin CH (1995) Improvement of an “In-Gel” digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal Biochem 224: 451–55. doi: 10.1006/abio.1995.1070
[24]
Nans A, Mohandas N, Stokes DL (2011) Native ultrastructure of the red cell cytoskeleton by cryo-electron tomography. Biophys J 101: 2341–50. doi: 10.1016/j.bpj.2011.09.050
[25]
De Felice C, Ciccoli L, Leoncini S (2009) Systemic oxidative stress in classic Rett syndrome. Free Radic Biol Med 47: 440–48. doi: 10.1016/j.freeradbiomed.2009.05.016
[26]
Pecorelli A, Ciccoli L, Signorini C (2011) Increased levels of 4HNE-protein plasma adducts in Rett syndrome. Clin Biochem 44: 368–71. doi: 10.1016/j.clinbiochem.2011.01.007
[27]
Leoncini S, De Felice C, Signorini C (2011) Oxidative stress in Rett syndrome: natural history, genotype, and variants. Redox Rep 16: 145–53. doi: 10.1179/1351000211y.0000000004
[28]
Signorini C, De Felice C, Leoncini S (2011) F4-neuroprostanes mediate neurological severity in Rett syndrome Clin Chim Acta. 412: 1399–1406. doi: 10.1016/j.cca.2011.04.016
[29]
De Felice C, Signorini C, Leoncini S (2012) The role of oxidative stress in Rett syndrome: an overview Ann NY Acad of Sci. 1259: 121–35. doi: 10.1111/j.1749-6632.2012.06611.x
[30]
Sticozzi C, Belmonte G, Cervellati F, Di Capua A, Maioli E, et al. (2013) Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes. Eur J Pharm Sci 49: 133–41. doi: 10.1016/j.ejps.2013.02.009
[31]
Uchida K (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42: 318–43. doi: 10.1016/s0163-7827(03)00014-6
[32]
Chik JK, Lindberg U, Schutt CE (1996) The structure of an open state of beta-actin at 2.65 A resolution. J Mol Biol 263: 607–23. doi: 10.1006/jmbi.1996.0602
[33]
Farah ME, Sirotkin V, Haarer B, Kakhniashvili D, Amberg DC (2011) Diverse protective roles of the actin cytoskeleton during oxidative stress. Cytoskeleton 68: 340–54. doi: 10.1002/cm.20516
[34]
Cobb S, Guy J, Bird A (2010) Reversibility of functional deficits in experimental models of Rett syndrome. Biochem Soc Trans 38: 498–506. doi: 10.1042/bst0380498
[35]
Giacometti E, Luikenhuis S, Beard C, Jaenisch R (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci USA 104: 1931–36. doi: 10.1073/pnas.0610593104
[36]
Gadalla KK, Bailey ME, Cobb SR (2011) MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Biochem J 439: 1–14. doi: 10.1042/bj20110648
[37]
Francke U (2006) Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat Clin Pract Neurol 2: 212–21. doi: 10.1038/ncpneuro0148
